Etcheberrigaray; Rene

Patent Applications and Registrations

Patent applications and USPTO patent grants for Etcheberrigaray; Rene.The latest application filed is for "methods for alzheimer's disease treatment and cognitive enhancement".

Company Profile

0.6.14

Etcheberrigaray; Rene - Bethesda MD
Etcheberrigaray; Rene - Clarksville MD
Etcheberrigaray, Rene - Columbia MD
Etcheberrigaray, Rene - Rockville MD
Etcheberrigaray, Rene - Columia MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for Alzheimer's disease treatment and cognitive enhancement Grant 9,539,235 - Etcheberrigaray , et al. January 10, 2	2017-01-10
Methods for Alzheimer'S disease treatment and cognitive enhancement Grant 9,446,020 - Etcheberrigaray , et al. September 20, 2	2016-09-20
Methods For Alzheimer's Disease Treatment And Cognitive Enhancement App 20160051509 - Etcheberrigaray; Rene ; et al.	2016-02-25
Methods For Alzheimer's Disease Treatment And Cognitive Enhancement App 20130281522 - Etcheberrigaray; Rene ; et al.	2013-10-24
PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS App 20130072550 - Etcheberrigaray; Rene ; et al.	2013-03-21
PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS App 20110196028 - Etcheberrigaray; Rene ; et al.	2011-08-11
Pkc activation as a means for enhancing sappalpha secretion and improving cognition using bryostatin type compounds App 20070037871 - Etcheberrigaray; Rene ; et al.	2007-02-15
Methods for Alzheimer's Disease treatment and cognitive enhancement App 20050037984 - Etcheberrigaray, Rene ; et al.	2005-02-17
Methods for Alzheimer's Disease treatment and cognitive enhancement Grant 6,825,229 - Etcheberrigaray , et al. November 30, 2	2004-11-30
Rigid pyrrolidone modulators of pkc App 20040019018 - Qlao, Lixin ; et al.	2004-01-29
Methods for alzheimer's disease treatment and cognitive enhancement App 20030171356 - Etcheberrigaray, Rene ; et al.	2003-09-11
Cell tests for Alzheimer's disease App 20030108956 - Alkon, Daniel L. ; et al.	2003-06-12
Phosphinylmethyl and phosphorylmethyl succinic and glutaric acid analogs as beta-secretase inhibitors App 20030078240 - Etcheberrigaray, Rene ; et al.	2003-04-24
Treatment of conditions associated with amyloid processing using PKC activators App 20030050302 - Etcheberrigaray, Rene ; et al.	2003-03-13
Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as B-secretase inhibitors App 20020187928 - Qiao, Lixin ; et al.	2002-12-12
Cell tests and diagnostic index for alzheimer's disease App 20020098520 - Alkon, Daniel L. ; et al.	2002-07-25
Cell tests for Alzheimer's disease Grant 6,080,582 - Alkon , et al. June 27, 2	2000-06-27
Cell tests for alzheimer's disease Grant 5,976,816 - Alkon , et al. November 2, 1	1999-11-02
Diagnostic tests for alzheimers disease Grant 5,580,748 - Alkon , et al. December 3, 1	1996-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.